69 related articles for article (PubMed ID: 8105147)
1. MDR-1 expression in metastatic malignant melanoma.
Levine EA; Holzmayer TA; Roninson IB; Das Gupta TK
J Surg Res; 1993 Jun; 54(6):621-4. PubMed ID: 8105147
[TBL] [Abstract][Full Text] [Related]
2. Expression of the multidrug resistance gene in osteosarcoma: a pilot study.
Wunder JS; Bell RS; Wold L; Andrulis IL
J Orthop Res; 1993 May; 11(3):396-403. PubMed ID: 8100852
[TBL] [Abstract][Full Text] [Related]
3. MDR1 gene expression in myelodysplastic syndrome and in acute myeloid leukemia evolving from myelodysplastic syndrome.
Zöchbauer S; Gsur A; Götzl M; Wallner J; Lechner K; Pirker R
Anticancer Res; 1994; 14(3B):1293-5. PubMed ID: 7915092
[TBL] [Abstract][Full Text] [Related]
4. Expression of the multidrug-resistant gene in human musculoskeletal tumors.
Nagata Y; Yamasaki H; Fukuda K; Tanaka S; Tsuruo T; Shuntoh H; Kuno T
J Environ Pathol Toxicol Oncol; 1992; 11(3):131-7. PubMed ID: 1352546
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients.
Nishizawa A; Nakanishi Y; Yoshimura K; Sasajima Y; Yamazaki N; Yamamoto A; Hanada K; Kanai Y; Hirohashi S
Cancer; 2005 Apr; 103(8):1693-700. PubMed ID: 15751018
[TBL] [Abstract][Full Text] [Related]
6. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines.
Zaman GJ; Versantvoort CH; Smit JJ; Eijdems EW; de Haas M; Smith AJ; Broxterman HJ; Mulder NH; de Vries EG; Baas F
Cancer Res; 1993 Apr; 53(8):1747-50. PubMed ID: 8467491
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of MDR1, LRP, MRP, and topoisomerase IIalpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines.
Miracco C; Maellaro E; Pacenti L; Del Bello B; Valentini MA; Rubegni P; Pirtoli L; Volpi C; Santopietro R; Tosi P
Int J Oncol; 2003 Jul; 23(1):213-20. PubMed ID: 12792796
[TBL] [Abstract][Full Text] [Related]
10. MDR1 gene expression in primary and advanced breast cancer.
Yang X; Uziely B; Groshen S; Lukas J; Israel V; Russell C; Dunnington G; Formenti S; Muggia F; Press MF
Lab Invest; 1999 Mar; 79(3):271-80. PubMed ID: 10092063
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal daunomycin induces multidrug resistance in proliferative vitreoretinopathy.
Esser P; Tervooren D; Heimann K; Kociok N; Bartz-Schmidt KU; Walter P; Weller M
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):164-70. PubMed ID: 9430558
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of expression of multidrug resistance gene in breast cancer tissue].
Liu X; Song S; Shi C
Zhonghua Yi Xue Za Zhi; 1997 Jul; 77(7):488-90. PubMed ID: 9772445
[TBL] [Abstract][Full Text] [Related]
13. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
[TBL] [Abstract][Full Text] [Related]
14. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
[TBL] [Abstract][Full Text] [Related]
15. Clinical relationship between MDR1 gene and gallbladder cancer.
Wang BL; Zhai HY; Chen BY; Zhai SP; Yang HY; Chen XP; Zhao WT; Meng L
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):296-9. PubMed ID: 15138130
[TBL] [Abstract][Full Text] [Related]
16. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
17. Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients.
Galani E; Sgouros J; Petropoulou C; Janinis J; Aravantinos G; Dionysiou-Asteriou D; Skarlos D; Gonos E
Anticancer Res; 2002; 22(4):2275-80. PubMed ID: 12174914
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma.
Lederman M; Meir T; Zeschnigk M; Pe'er J; Chowers I
Curr Eye Res; 2008 Oct; 33(10):876-84. PubMed ID: 18853322
[TBL] [Abstract][Full Text] [Related]
19. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
20. Comparison of multidrug resistance gene expression levels with malignant potentials and influence of chemotherapy in urothelial cancers.
Kakehi Y; Wu WJ; Kim WJ; Arao S; Fukumoto M; Yoshida O
Int J Urol; 1995 Nov; 2(5):309-15. PubMed ID: 8749949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]